What Makes Repligen Corporation (RGEN) an Investment Choice?
Baron Funds, an investment management company, released its fourth-quarter investor letter for the “Baron Health Care Fund”. A copy of the letter can be downloaded here.
Repligen Corp (RGEN)
Market is closed
Hedge Fund Popularity
Hedge Fund Holdings
Filing Period: Filing is Ongoing
Last updated on based on SEC 13F filings Last update:
| No. | Hedge Fund | Shares | Value | Activity | % Port |
|---|---|---|---|---|---|
| 1. | Impax Asset Management Ian Simm | 413,384 | $67,737,102 | -42% | 0.42% |
| 2. | Bayforest Capital Theodoros Tsagaris | 195 | $31,953 | 0.02% | |
| 3. | Sivik Global Healthcare Krishen Sud | 25,000 | $4,097 | -10% | 1.19% |
Insider Trading: Purchases See All
| Insider | Price | Amount | Total Value | Remaining Holdings | Date | Form 4 |
|---|---|---|---|---|---|---|
| $112.13 | 1,800 | $201,830.40 | 1,800 | 2025-08-08 | Filing | |
| $150.69 | 250 | $37,672.50 | 1,043 | 2025-03-17 | Filing | |
| $125.46 | 700 | $87,822.00 | 4,613 | 2024-06-14 | Filing | |
| $124.54 | 915 | $113,954.10 | 3,913 | 2024-06-14 | Filing | |
| $125.45 | 1,200 | $150,540.00 | 4,668 | 2024-06-14 | Filing |
Insider Trading: Sales See All
| Insider | Price | Amount | Total Value | Remaining Holdings | Date | Form 4 |
|---|---|---|---|---|---|---|
| $161.00 | 275 | $44,275.00 | 91,821 | 2025-12-17 | Filing | |
| $170.00 | 7,041 | $1,196,970.00 | 35,898 | 2025-11-25 | Filing | |
| $151.21 | 2,191 | $331,301.11 | 21,520 | 2025-11-18 | Filing | |
| $157.11 | 1,956 | $307,307.16 | 80,743 | 2025-11-13 | Filing | |
| $156.22 | 5,737 | $896,234.14 | 82,699 | 2025-11-13 | Filing |
Institutional Investors' Holdings
Filing Period: Filing is Ongoing
| No. | Name | Shares | Value | % Port |
|---|---|---|---|---|
| 1. | 4,993,945 | $818,307,828 | 0.01% | |
| 2. | 1,215,527 | $199,176,255 | 0.06% | |
| 3. | 1,057,975 | $173,359,783 | 2.92% | |
| 4. | 746,306 | $122,289,701 | 0.86% | |
| 5. | 657,111 | $107,674,208 | 1.4% |
News See All
UBS Tags Repligen (RGEN) as Bioprocessing Leader for 2026, Cites 20% Order Growth and Reshoring Tailwinds
Repligen Corporation (NASDAQ:RGEN) is one of the best mid-cap growth stocks to buy right now.
14 Best Mid-Cap Growth Stocks to Buy Right Now
On January 8, Nancy Prial, Co-CEO & Senior Portfolio Manager at Essex Investment Management, appeared on CNBC and suggested she sees significant upside in 2026 for undiscovered small- and midcap firms...
Here’s Why Sands Capital Global Growth Fund Decided to Sell Repligen Corporation (RGEN)
Sands Capital, an investment management company, released its “Sands Capital Global Growth Fund” third-quarter 2025 investor letter. A copy of the letter can be downloaded here.
Is Repligen (RGEN) The Best Healthcare Stock to Buy Now?
Dan Veru, Palisade Capital Management senior partner and CIO, recently talked about Repligen, a life sciences company involved in the development and production of materials used in the manufacture of...
Top 10 Stock Recommendations You Can’t Miss Amid Growing AI Bubble Fears
Blockbuster AI deals with eye-popping numbers have started to make Wall Street uneasy amid growing concerns about stock valuations and parallels between today’s AI boom and the dot-com bubble.
Repligen Corporation (NASDAQ:RGEN) Q2 2025 Earnings Call Transcript
Operator: Good day, ladies and gentlemen, and welcome to Repligen Corporation's Second Quarter of 2025 Earnings Conference Call. My name is Greg, and I will be your coordinator.
Does Repligen Corp (RGEN) Have a Strong Pricing Power?
Prosper Stars & Stripes, a long/short equity fund, recently released its first quarter 2025 investor letter. A copy of the letter can be downloaded here.
Repligen Corp. (RGEN) Slid On Uncertainty Related To U.S. Federal Government Spending On Healthcare
Conestoga Capital Advisors, an asset management company, released its first-quarter 2025 investor letter. A copy of the letter can be downloaded here.
Jim Cramer Listed 20 Best Performing Stocks of the Last 20 Years
“This week we're celebrating the show's 20th anniversary, a little over a month late, but better late than never.
Hedge Fund Resource Center Billionaire Hedge Funds
